Daniel Martin Klotz
6PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 16, 2024
The prognostic influence of hospital type, method of first histological confirmation and time to chemotherapy in patients with advanced primary ovarian cancer.Olivia Starke, Pauline Wimberger, Daniel Martin Klotz
|Oct 10, 2023
A predictive and prognostic model for surgical outcome and prognosis in ovarian cancer computed by clinico-pathological and serological parameters (CA125, HE4, mesothelin).Daniel Martin Klotz, Theresa Link, Pauline Wimberger
|Oct 23, 2021
Evaluation of circulating Dickkopf-1 as a prognostic biomarker in ovarian cancer patients.Daniel Martin Klotz, Theresa Link, Maren Goeckenjan
|Mar 19, 2021
Prognostic relevance of longitudinal HGF levels in serum of patients with ovarian cancer.Daniel Martin Klotz, Theresa Link, Pauline Wimberger
|Mar 10, 2021
The levels of soluble cMET ectodomain in the blood of patients with ovarian cancer are an independent prognostic biomarker.Daniel Martin Klotz, Theresa Link, Maren Goeckenjan
|Aug 25, 2020
Overcoming PARP inhibitor resistance in ovarian cancer: what are the most promising strategies?Daniel Martin Klotz, Pauline Wimberger
Pageof 1
